0001209191-19-017464.txt : 20190306 0001209191-19-017464.hdr.sgml : 20190306 20190306173800 ACCESSION NUMBER: 0001209191-19-017464 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190227 FILED AS OF DATE: 20190306 DATE AS OF CHANGE: 20190306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huller Kelly CENTRAL INDEX KEY: 0001768417 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35621 FILM NUMBER: 19663590 MAIL ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDOBON STATE: PA ZIP: 19403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBUS MEDICAL INC CENTRAL INDEX KEY: 0001237831 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043744954 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 BUSINESS PHONE: 610-930-1800 MAIL ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2019-02-27 0 0001237831 GLOBUS MEDICAL INC GMED 0001768417 Huller Kelly VALLEY FORGE BUSINESS CENTER 2560 GENERAL ARMISTEAD AVENUE AUDUBON PA 19403 0 1 0 0 SVP, General Counsel Class A Common Stock 15384 D Stock Option (Right to Buy Class A Common Stock) 11.86 2020-06-16 Class A Common Stock 3076 D Stock Option (Right to Buy Class A Common Stock) 11.28 2021-02-11 Class A Common Stock 23076 D Stock Option (Right to Buy Class A Common Stock) 15.34 2022-08-29 Class A Common Stock 2500 D Stock Option (Right to Buy Class A Common Stock) 12.59 2023-01-30 Class A Common Stock 7500 D Stock Option (Right to Buy Class A Common Stock) 24.90 2024-03-04 Class A Common Stock 7500 D Stock Option (Right to Buy Class A Common Stock) 25.80 2025-04-01 Class A Common Stock 7500 D Stock Option (Right to Buy Class A Common Stock) 24.21 2026-02-02 Class A Common Stock 7500 D Stock Option (Right to Buy Class A Common Stock) 25.96 2027-02-02 Class A Common Stock 7500 D Stock Option (Right to Buy Class A Common Stock) 45.64 2028-02-02 Class A Common Stock 10000 D Stock Option (Right to Buy Class A Common Stock) 43.58 2029-01-22 Class A Common Stock 40000 D These options were granted on June 16, 2010 and are fully vested. These options were granted on February 11, 2011 and are fully vested. These options were granted on August 29, 2012 and are fully vested. These options were granted on January 30, 2013 and are fully vested. These options were granted on March 4, 2014 and are fully vested. These options were granted on April 1, 2015 and are fully vested. These options were granted on February 2, 2016, and vest over a four-year period with one-fourth(1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on February 2, 2017, and vest over a four-year period with one-fourth(1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on February 2, 2018, and vest over a four-year period with one-fourth(1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. /s/ Kelly G. Huller 2019-03-06 EX-24.3_840493 2 poa.txt POA DOCUMENT Know all by these presents that the undersigned hereby constitutes and appoints Adam M. Cole, acting alone, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director and/or 10% or more stockholder of Globus Medical, Inc. (the "Company"), Forms ID, 3, 4, 5 and Update Passphrase Acknowledgement (and any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "1934 Act"), and the rules promulgated thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form ID, 3, 4, 5 and Update Passphrase Acknowledgement (and any amendments thereto) and to file timely such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which in the opinion of such attorney-in-fact may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the 1934 Act. This Power of Attorney revokes any and all prior powers of attorney and shall remain in full force and effect until the undersigned is no longer required to file Forms ID, 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 5 day of March 2019. /s/ Kelly G. Huller Kelly G. Huller